ARCT News and Press, Arcturus Therapeutics Ltd. From 11/10/22

Baird downgraded the RNA therapeutics company Arcturus Therapeutics ( NASDAQ: ARCT ) on Thursday, citing an uncertain outlook for its recently announced partnership with Australia-based CSL Limited ( OTCPK:CSLLY ) ( OTC:CMHXF ) and seeing a delay in a key development pro...

Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2022 Results Conference Call November 09, 2022 04:30 PM ET Company Participants Kyle Gutsadt - Investor Relations Joseph Payne - President and Chief Executive Officer Andrew Sassine - Chief Financial Officer Padma...

Arcturus Therapeutics press release ( NASDAQ: ARCT ): Q3 GAAP EPS of -$1.33 beats by $0.44 . Revenue of $13.4M (+449.2% Y/Y) beats by $9.31M . The Company’s cash balance totaled $237.7M as of September 30, 2022, compared to a cash balance of $370.5M at D...

Entered into global partnership with CSL to develop and commercialize self-amplifying mRNA vaccines targeting COVID-19, influenza, additional pathogens, and pandemic preparedness with $200 million upfront and up to $4.3 billion in potential development and commercial milestones ...

Arcturus Therapeutics Holdings Inc. (the “Company,” “Arcturus,” Nasdaq: ARCT), a global, late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory r...

Citi has upgraded Arcturus Therapeutics to buy from neutral saying that the company's recent strategic collaboration with CSL Sequirus validates its mRNA platform. The firm has a $35 price target (~61% upside based on Wednesday's close). Analyst Yigal Nochomovitz noted tha...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ricochet64 / Shutterstock.com Rogers Corporation (NYSE: ROG ) stock is falling hard on Wednesday following confirmation that DuPont (NYSE: DD ) no longer plans to acquire the company. Several sou...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock.com Benefitfocus (NASDAQ: BNFT ) stock is rocketing higher on Wednesday as investors react to a $570 million acquisition deal with Voya Financial (NYSE: VOYA ). That deal will see ...

Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) are skyrocketing today, up by 26.5% as of 11:15 a.m. ET. The huge gain came after Arcturus announced yesterday that it has entered into a strategic collaboration with CSL Seqirus, a unit of CSL Limited (OTC: CSLL.Y) . T...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips A strategic collaboration has today’s traders talking about Arcturus Therapeutics (NASDAQ: ARCT ) and CSL (OTCMKTS: CSLLY ). Reportedly, the two companies will work together on mRNA technology for a w...